Driving Veterinary Antimicrobial Susceptibility Testing Market Growth in 2025: The Role of Veterinary Antimicrobial Susceptibility Testing Market On The Rise Amidst Increasing Zoonotic Disease Prevalence

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

Veterinary Antimicrobial Susceptibility Testing Market Size Growth Forecast: What to Expect by 2025?
The size of the veterinary antimicrobial susceptibility testing market has seen sturdy growth in recent times. The market value which is expected to be at $37.12 billion in 2024, will escalate to $39.71 billion in 2025, with a compound annual growth rate (CAGR) of 7.0%. The significant growth observed in the historic period can be credited to factors such as environmental issues, the requirement for precision medicine, the one health approach, growing consumer knowledge, and the expansion of companion animal healthcare.

How Will the Veterinary Antimicrobial Susceptibility Testing Market Size Evolve and Grow by 2029?
The size of the veterinary antimicrobial susceptibility testing market is projected to experience significant growth in the upcoming years, reaching $53.96 billion in 2029 with an 8.0% compound annual growth rate (CAGR). The escalation during the prediction period can be ascribed to the reduction of antibiotic resistance, legislative mandates, the influence of worldwide health incidents, and an increase in pet ownership. Leading trends throughout the prediction period are expected to involve innovative solutions, regulatory focus, management of zoonotic diseases, and livestock industry norms.

View the full report here:
https://www.thebusinessresearchcompany.com/report/veterinary-antimicrobial-susceptibility-testing-global-market-report

What Drivers Are Propelling the Growth of Veterinary Antimicrobial Susceptibility Testing Market Forward?
The escalating occurrence of zoonotic diseases is projected to drive the expansion of the veterinary antimicrobial susceptibility testing market in the future. Zoonotic diseases are infectious diseases that can be transmitted from one animal species to another, including from humans to animals or among humans. The growing incidence of these diseases necessitates the testing and determination of the most effective animal medication. Veterinary antimicrobial susceptibility testing assists in the selection of the optimal drug to manage bacterial infections in animals by reviewing treatment history, among other factors. An example of this is that in July 2022, a World Health Organization article reported that a US-based government agency identified a 64% surge in the number of zoonotic cases in Africa. Moreover, zoonotic diseases are escalating worldwide, including in India. These emerging infectious diseases in humans account for 60% of instances, with 816 out of 1407 human pathogens being zoonotic. Hence, the escalating occurrence of zoonotic diseases is propelling the growth of the veterinary antimicrobial susceptibility testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8177&type=smp

Which Emerging Trends Are Transforming the Veterinary Antimicrobial Susceptibility Testing Market in 2025?
The rise in technological advancements is becoming a prominent trend in the veterinary antimicrobial susceptibility testing market. This is mainly due to major companies in the veterinary market pushing for innovation in order to maintain their market standing. The market has recently seen the application of sophisticated imaging techniques and algorithms to improve the speed, accuracy, and reliability of veterinary AST tests. For example, the French biotech company bioMérieux was granted FDA 510(k) clearance for their cutting-edge VITEK MS PRIME, a MALDI-TOF1 mass spectrometry identification system, in March 2022. With this FDA clearance, the system is now available for commercial purchase in countries where CE-marking is recognized, as well as in the United States. The system provides swift and accurate identification of pathogens, assisting in rapid and more precise antimicrobial treatment.

What Are the Key Segments in the Veterinary Antimicrobial Susceptibility Testing Market?
The veterinary antimicrobial susceptibility testing market covered in this report is segmented -

1) By Product Type: Disks And Plates, Culture Media, Accessories And Consumables, Automated AST (Antimicrobial Susceptibility Test) Instruments
2) By Animal Type: Livestock Animals, Companion Animals
3) By End-Use: Veterinary Reference Lab, Veterinary Research Institutes, Other End-Users

Subsegments:
1) By Disks And Plates: Antibiotic Disks, Agar Plates
2) By Culture Media: Selective Culture Media, General Purpose Media
3) By Accessories And Consumables: Incubators, Sterilization Equipment, Pipettes And Reagents
4) By Automated AST (Antimicrobial Susceptibility Test) Instruments: Fully Automated Systems, Semi-Automated Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8177&type=smp

Who Are the Key Players Shaping the Veterinary Antimicrobial Susceptibility Testing Market's Competitive Landscape?
Major companies operating in the veterinary antimicrobial susceptibility testing market are BioMérieux SA, Becton, Dickinson and Company, Bio-Rad Laboratories, Bruker Corporation, Condalab SA, FASTinov SA, Hardy Diagnostics Co., HiMedia Laboratories, Liofilchem Srl, Mast Group Ltd., Neogen Corporation, SSI Diagnostica A/S, Synbiosis, Thermo Fisher Scientific Inc., Accelerate Diagnostics Inc., Alifax S.r.l., Biogal Galed Labs Ltd., Creative Diagnostics, Danaher Corporation, Eurofins Scientific SE, IDEXX Laboratories Inc., Merck Co. & KGaA, Microbiologics Inc., QIAGEN N.V., R-Biopharm AG, T2 Biosystems Inc., Vetoquinol S.A., Virbac Inc., Zoetis Inc.

What Geographic Markets Are Powering Growth in the Veterinary Antimicrobial Susceptibility Testing Market?
North America was the largest region in the veterinary antimicrobial susceptibility testing market in 2024. The regions covered in the veterinary antimicrobial susceptibility testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8177

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.